A Systematic Review Onphy to Chemicals Having Vascular Protective Effects
Main Article Content
Abstract
Vascular endothelial dysfunction, characterized by imbalances in vasodilation and constriction, deficiency of nitric oxide bioavailability, and elevated reactive oxygen species, is a key factor in cardiovascular diseases like hypertension, atherosclerosis, and diabetes. Regular consumption of medicinal plants, fruits, and vegetables can promote vascular health and lower the risk of cardiovascular diseases. Phytochemical compounds found in these resources, such as curcumin have potential therapeutic agents for vascular dysfunction due to their antioxidative mechanisms. However, further human studies are needed to confirm these
effects. Also, medicinal properties against CVDs of 4 widely used plants namely ginseng, ginkgo biloba, Ganoderma lucidum, gynostemma pentaphyllum are discussed in this review to provide recent information on their vascular protective mechanisms in vivo and in vitro. However, future human studies will be necessary to confirm the clinical effects of these vascular protective mechanisms. Finally, we reviewed and reported the results of the recent clinical trials and have been conducted using these medicinal herbs with special emphasis on their efficacy, safety, and toxicity. Marketed formulations and case studies regarding to vascular protective effect are also mentioned. Our study aimed to analyse and compare monthly costs along with cost variation between Ayurveda and Allopathy medicines used to treat 2 chronic disease conditions, viz. Atherosclerosis and Hypertension. The prices of Allopathic & Ayurvedic drugs mentioned in the treatment guidelines for these 2 conditions were obtained from different sources. In the case of Allopathic drugs, the %CVD ranged from 182%for DMARDs to 1184.39% for Corticosteroids. In the case of Anti-hypertensive medicines, too, the mean %CVD ranged from 84.21% for Rasaushadhi to 353.33% for Arishta, while %CVD ranged from 150.70% for ACE inhibitors to 269.85% for Calcium channel blockers for Ayurvedic and Allopathic medicines, respectively.
References
Kamaruddin Nur.
Vascular protective effect and its possible mechanism of action on active phytocompounds.
PMC PubMed Central PMCID: PMC9034927 / PMID: 35469164, 2022.
Shaito R, Abdullah G, Hasan H, Pintus G.
Herbal medicine for cardiovascular diseases.
Frontiers in Pharmacology. 2020; Volume 11.
Cox F.F., Misiou A., Vierkant A., Ale-Agha N.
Protective effects of curcumin in cardiovascular diseases – impact on oxidative stress and mitochondria.
PMC PubMed Central. 2022 Jan 20.
Dal Stephanie, Sigrist Séverine.
The protective effects of antioxidants consumption on diabetes and vascular complications.
PMC PubMed Central PMCID: PMC5456287, 2016.
Sinha A, et al.
Coronary microvascular diseases: current concepts of pathophysiology, diagnosis, and management.
PMC PubMed Central PMCID: PMC7901821, PMID: 33634252; 10(1):22–30.
Hadi HA, et al.
Endothelial dysfunction: cardiovascular risk factors.
Vascular Health and Risk Management. 2005;1(3):183–189.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993955/
Abbelazim A, Khater S, Ali H, Shalaby S, Afifi M, Saddick S, et al. (2018).
Panax ginseng improves glucose metabolism in streptozotocin-induced diabetic rats through 5′ adenosine monophosphate kinase up-regulation.
Saudi Journal of Biological Sciences.
Gimbrone MA Jr., García-Cardeña G.
Endothelial cell dysfunction and the pathobiology of atherosclerosis.
Circulation Research. 2016;118:620–636.
Welsh P, Grassia G, Botha S, Sattar N, Maffia P.
Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
British Journal of Pharmacology. 2017;174(22):3898–3913.
Indrayan A.
Epidemiology of hypertension.
J Assoc Physicians India. 1994;42(2):175–176.
Aiello VD, Ramarez HS, Nunes RA.
Women with ischemic heart disease admitted due to chest pain and shock.
ABC Cardiol Journal. Dec 2018.
Gidlow CJ, Ellis NJ, Cowap L.
Cardiovascular disease risk communication in NHS health checks using QRISK and JBS3 risk calculators: the RICO qualitative and quantitative study.
Health Technology Assessment (HTA). Dec 2020.
Ratan Kumar, Vaibhav Kumar, Shweta Kachhap.
Cost analysis study of antihypertensive agents available in India.
Indian Journal of Pharmacy and Pharmacology. 2020(3):181–183.
Renuka Munshi, Vivek Singh.
A cost comparison and cost variation analysis of anti-rheumatoid drugs and anti-hypertensive drugs in Ayurveda and Allopathy.
JK Welfare and Pharmascope Foundation. 24 Dec 2021.
Yousefian M, Shakour N, Hosseinzadeh H.
Natural phenolic compounds as modulators of NADPH oxidases in hypertension.
Phytomedicine. 2019;55:200–213.
